Highlights ASIT biotech CINNOBER BOAT

Equities

0RGO

BE0974289218

End-of-day quote CINNOBER BOAT Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-.--%	-.--%

2023	DMS Imaging SA Reports Earnings Results for the Half Year Ended June 30, 2023	CI
2023	DMS Imaging SA Reports Earnings Results for the Full Year Ended December 31, 2022	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

DMS Imaging SA Reports Earnings Results for the Half Year Ended June 30, 2023	21/09/23	CI
DMS Imaging SA Reports Earnings Results for the Full Year Ended December 31, 2022	28/04/23	CI
Diagnostic Medical Systems Unit Receives Order for Radiology Tables in Italy	12/01/23	MT
DMS Imaging SA Reports Earnings Results for the Half Year Ended June 30, 2022	30/09/22	CI
DMS Imaging SA Reports Earnings Results for the Full Year Ended December 31, 2021	30/04/22	CI
Diagnostic Medical Systems Takes Majority Stake In Asit Biotech	25/01/22	MT
Global markets live: Microsoft, Apple, The Boeing Company, AT&T, Activision Blizzard...	15/09/21
Asit Biotech S.A. Reports Earnings Results for the Half Year Ended June 30, 2020	30/09/20	CI
Asit Biotech S.A. Reports Earnings Results for the Full Year Ended December 31, 2019	06/05/20	CI
ASIT biotech Discloses Next Steps Following gp-ASIT+TM Phase III Results	20/12/19	CI
ASIT Biotech gp-ASIT+™ Phase III Trial in Grass Pollen Allergy Did Not Meet the Primary Endpoint	25/11/19	CI
ASIT Biotech Announces the Publication of a Mechanistic Study of Gp-ASIT+™, its Lead Product Candidate in Phase III	17/10/19	CI
ASIT Biotech Receives GMP Certification for Its Manufacturing Site in Liège, Belgium	07/10/19	CI
Biotech Tools Sa Reports Earnings Results for the Half Year Ended June 30, 2019	18/09/19	CI
ASIT biotech Confirms on Track for Phase III Results of gp-ASIT+™ in December 2019	05/09/19	CI
ASIT Biotech Announces the Achievement of New Clinical and Corporate Development Milestones	02/05/19	CI
ASIT Biotech Appoints Frank Hazevoets as Chief Financial Officer	02/05/19	CI
ASIT Biotech S.A. Reports Earnings Results for the Full Year Ended December 31, 2018	02/04/19	CI
ASIT Biotech S.A. Provides Clinical Update	02/04/19	CI
ASIT Biotech S.A. Reveals the Mode of Action of its Immunotherapy Product for Allergic Rhinitis, gp-ASIT+™, in the Journal of Allergy and Clinical Immunology	05/03/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights ASIT biotech CINNOBER BOAT

Equities

0RGO

BE0974289218

Highlights

Filters